Pharma-Bio Serv, Inc.
PBSV
$0.55
$0.07515.79%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 16.10K | -309.20K | -213.80K | -270.70K | -47.10K |
| Total Depreciation and Amortization | 46.50K | 44.40K | 44.70K | 45.60K | 44.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.60K | -58.40K | -11.10K | -167.40K | -141.40K |
| Change in Net Operating Assets | -22.80K | -347.20K | -520.50K | 1.12M | 452.00K |
| Cash from Operations | 78.40K | -670.30K | -700.70K | 725.90K | 308.40K |
| Capital Expenditure | -157.00K | -1.90K | -- | -800.00 | 1.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 328.50K | 3.69M | -458.90K | -4.76M | 7.33M |
| Cash from Investing | 171.50K | 3.69M | -458.90K | -4.76M | 7.33M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | -1.70K | -2.30K | -7.20K | -800.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -- | -1.72M | -- | 0.00 |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | -1.70K | -1.72M | -7.20K | -800.00 |
| Foreign Exchange rate Adjustments | -2.80K | -7.10K | -19.90K | 12.10K | -58.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 247.20K | 3.01M | -2.90M | -4.03M | 7.58M |
